These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Adverse effects and complications in long term corticoid treatment in the metabolic and endocrine fields]. Baquet R Maroc Med; 1969; 49(527):479-81. PubMed ID: 5398367 [No Abstract] [Full Text] [Related]
8. [Drug-induced disturbances in endocrine, metabolism, and water and electrolyte metabolism]. Hayashi M Nihon Rinsho; 2007 Oct; 65 Suppl 8():137-42. PubMed ID: 18072341 [No Abstract] [Full Text] [Related]
9. [General view of the oral prevention of pregnancy]. Potts DM Katilolehti; 1970 Oct; 75(10):414-8. PubMed ID: 5203907 [No Abstract] [Full Text] [Related]
10. [Toxicity of antimycobacterial drugs. 20 years of experience in therapy of tuberculosis]. Battigelli G; Babich S; Pastorelli S Minerva Med; 1971 Feb; 62(16):730-4. PubMed ID: 5576136 [No Abstract] [Full Text] [Related]
11. Myths about endocrine disruption and the male reproductive system should not be propagated. Joffe M Hum Reprod; 2002 Feb; 17(2):520-3. PubMed ID: 11821308 [No Abstract] [Full Text] [Related]
12. [Neuropsychiatric disorders while using hormonal contraceptives (review)]. Burtsev EM Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1391-401. PubMed ID: 6391050 [No Abstract] [Full Text] [Related]
13. [Contraceptives for oral use and related public health problems]. Macchai G Ann Sanita Pubblica; 1967; 28(5):1129-52. PubMed ID: 5629384 [No Abstract] [Full Text] [Related]
14. Drug-induced endocrine and metabolic disorders. Ben Salem C; Slim R; Elouni B; Hmouda H; Bouraoui K Drug Saf; 2007; 30(8):727-8; author reply 728-9. PubMed ID: 17696585 [No Abstract] [Full Text] [Related]
15. Diethylstilbestrol (DES)-related endocrine disturbances in women. A story with no end, yet. Assies J; Vonk J; Bleker O; Lumey L Ann N Y Acad Sci; 1995 Jun; 761():369-72. PubMed ID: 7625738 [No Abstract] [Full Text] [Related]
16. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802 [TBL] [Abstract][Full Text] [Related]
18. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124 [TBL] [Abstract][Full Text] [Related]
19. Testing the pill. Br Med J; 1969 Mar; 1(5644):592. PubMed ID: 5772982 [No Abstract] [Full Text] [Related]
20. [Risk in metabolic diseases, endocrine diseases, hormonal therapy and in pregnancy]. Ries W Stomatol DDR; 1980 Oct; 30(10):713-8. PubMed ID: 6936917 [No Abstract] [Full Text] [Related] [Next] [New Search]